Frequently asked question
What should leadership do in the first 72 hours after receiving an FDA Form 483?
Leadership should resist the urge to begin drafting immediately. The first priority is to determine what FDA may be testing through each observation, reconstruct the evidence chain, identify affected products and systems, and establish…
Answer
Leadership should resist the urge to begin drafting immediately. The first priority is to determine what FDA may be testing through each observation, reconstruct the evidence chain, identify affected products and systems, and establish clear ownership. A disciplined triage should distinguish immediate correction, interim control, root-cause work, CAPA, retrospective review, and longer-term remediation. The response becomes stronger when the organization first builds an evidence map, risk map, ownership map, and remediation logic rather than treating the Form 483 as a writing exercise.
Connected intelligence
Continue through the evidence graph.
Article
OOS Root Cause Analysis — Moving Beyond ‘Analyst Error’
"Analyst error" is not a root cause — it is a conclusion in search of evidence, and FDA’s May 2022 Level 2 revised OOS guidance is…Article
Chiral Drug Substances: Stereospecific Synthesis, Enantiomeric Purity, and the ICH Q6A Specification Strategy
More than half of the small molecule drugs approved by FDA in any given year contain at least one stereocenter. For most of those programs, the…Article
CAPA Effectiveness Verification — Closing the Loop FDA Actually Closes
An FDA investigator reviewing your CAPA system is not interested in how many CAPAs you have opened — they are interested in how many you have…Article
CareFusion 213, LLC (BD) Class I Recall — ChloraPrep Sterile Antiseptic Applicators: The Sterile Manufacturing System Failure Behind the Recall and What Every Aseptic Processing Director Must Address
CareFusion 213, LLC, a subsidiary of Becton, Dickinson and Company (BD), has recalled two configurations of its BD ChloraPrep One-Step and FREPP Clear sterile antiseptic applicators…When the answer needs context
Connect the question to the evidence and the decision.
Use XGene intelligence or bring the specific technical situation into a focused conversation.